Keyphrases
Vaccine Effectiveness
100%
Dendritic Cell Tumor
100%
Anti-CD25 Antibody
100%
Murine Melanoma Model
100%
Fusion Vaccine
100%
Clinical Trials
33%
Monoclonal Antibody
33%
Interleukin-12 (IL-12)
33%
Treg
33%
Dendritic Cells
33%
Pulmonary Metastasis
33%
IFN-γ ELISPOT
33%
Functional Inactivation
33%
CD4+ T
16%
ELISpot Assay
16%
Tumor Cells
16%
Malignancy
16%
Metastasis
16%
In Cancer
16%
Therapeutic Efficacy
16%
Immune System
16%
Immunostimulatory
16%
Tumor Immunity
16%
Blockage
16%
Antitumor
16%
Melanoma
16%
Tumor Antigen
16%
B16 Melanoma
16%
Regulatory T Cells
16%
Wilcoxon Rank Sum Test
16%
Splenocytes
16%
Cytotoxic CD8+ T Cells
16%
Combination Treatment
16%
Clinical Impact
16%
Helper Cells
16%
Aides
16%
Tumor-specific
16%
Cancer Vaccine
16%
Vaccine Administration
16%
Murine Studies
16%
CD4+CD25+Foxp3+ Treg
16%
Melanoma Model
16%
Cancer Vaccination
16%
Cancer Immunity
16%
Model Trial
16%
Therapeutic Impact
16%
Tumor Vaccination
16%
Immunology and Microbiology
Vaccine Efficacy
100%
Dendritic Cell
100%
Basiliximab
100%
Vaccine
100%
Regulatory T Cell
50%
Immunotherapy
37%
CD4
25%
Monoclonal Antibody
25%
Tumor Immunity
25%
ELISPOT
12%
Enzyme-Linked Immunospot Assay
12%
Tumor Cell
12%
Cytotoxic T Cell
12%
Immune System
12%
T Helper Cell
12%
Tumor Antigen
12%
CD8
12%
Splenocyte
12%
CD25
12%
Immunology
12%
Tumor Vaccine
12%